# Cardiol Therapeutics Sets Up $75 Million Share-Sale Program

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/48046
Published: 2026-11-03T22:30:38.000Z
Updated: 2026-11-03T22:30:38.000Z
Section: Business

> The company plans to use proceeds to support development of CardiolRx for recurrent pericarditis.

Cardiol Therapeutics announced Tuesday a share-sale program of up to $75 million, giving the company a way to raise money over time for CardiolRx development in recurrent pericarditis.

The at-the-market program will be conducted through Jefferies. It allows Cardiol to sell shares over time at prices prevailing in the market.

Cardiol plans to use the proceeds to support development of CardiolRx for recurrent pericarditis.